Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis

被引:71
作者
Abraham, Jerrold L. [1 ]
Thakral, Charu [1 ]
机构
[1] Upstate Med Univ, SUNY Albany, Dept Pathol, Syracuse, NY 13210 USA
关键词
gadolinium; transmetallation; biodistribution; toxicology; scanning electron microscopy; tissue microanalysis;
D O I
10.1016/j.ejrad.2008.01.026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Gadolinium (Gd) released from Gd-based MR contrast agents is the likely etiologic agent of nephrogenic systemic fibrosis (NSF). The biodistribution and kinetics of both chelated Gd and free Gd3+ are reviewed, including demonstrations of Gd in tissues of NSF patients. The purpose of this review is to consolidate the available information on distribution, metabolism, excretion and retention of Gd with particular emphasis on the possible mechanisms in the development of NSF. We also raise serious concern about the growing tissue burden of Gd with the release of Gd from its chelates and its yet unknown consequences. The development of NSF as well as potential long-term consequences of tissue Gd retention represent a part of the spectrum of Gd toxicity. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:200 / 207
页数:8
相关论文
共 50 条
  • [21] Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure
    Othersen, Jennifer B.
    Maize, John C.
    Woolson, Robert F.
    Budisavljevic, Milos N.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3179 - 3185
  • [22] Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness
    Canavese, Caterina
    Mereu, M. Cristina
    Aime, Silvio
    Lazzarich, Elisa
    Fenoglio, Roberta
    Quaglia, Marco
    Stratta, Piero
    JOURNAL OF NEPHROLOGY, 2008, 21 (03) : 324 - 336
  • [23] Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents
    Penfield, Jeffrey G.
    PEDIATRIC NEPHROLOGY, 2008, 23 (12) : 2121 - 2129
  • [24] Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis
    Peak, Amy S.
    Sheller, Amy
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (09) : 1481 - 1485
  • [25] Nephrogenic systemic fibrosis in a gadolinium-naive renal transplant recipient
    Anavekar, Namrata S.
    Chong, Alvin H.
    Norris, Richard
    Dowling, John
    Goodman, David
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2008, 49 (01) : 44 - 47
  • [26] Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
    Tamburrini, O.
    Balducci, A.
    RADIOLOGIA MEDICA, 2012, 117 (01): : 1 - 5
  • [27] Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case
    Bainotti, S.
    Rota, E.
    Bertrero, M.
    Tamburrini, O.
    Balducci, A.
    Formica, M.
    CLINICAL NEPHROLOGY, 2008, 70 (06) : 514 - 517
  • [28] Dermal inorganic gadolinium concentrations:: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis
    Abraham, J. L.
    Thakral, C.
    Skov, L.
    Rossen, K.
    Marckmann, P.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (02) : 273 - 280
  • [29] Gadolinium deposition in nephrogenic systemic fibrosis: An examination of tissue using synchrotron x-ray fluorescence spectroscopy
    High, Whitney A.
    Ranville, James F.
    Brown, Mariah
    Punshon, Tracy
    Lanzirotti, Antonio
    Jackson, Brian P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 38 - 44
  • [30] Nephrogenic Systemic Fibrosis
    Nainani, Neha
    Panesar, Mandip
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (01) : 1 - 9